How do production, market, pricing, development, and regulatory assumptions shape the plan?
Model profile
Pharmaceuticals
Production-parity dosage-form manufacturing, unit economics, reporting, financing, bankability, and investment returns.
Decision scope
Questions this model helps you examine
What operating capacity, working capital, investment, and financing are required?
How do risk, bankability, and downside cases affect funding needs and returns?
Model capabilities
What this model includes
The profile below is generated from the same catalogue and workspace definitions used by the application.
- Complete production and operating schedule pack
- Three statements, working capital, inventory, and debt
- Bankability, downside, scenario, sensitivity, and Monte Carlo analysis
- ML forecast plus project-document AI and RAG
- XLSX, PDF, Word, CSV bundle, and JSON exports
Build the case
Inputs and workspaces
- AssumptionsOperating, tax, financing, analytics, and bankability controls
- Products & productionUnit economics, capacity, volume, and price schedules
- OperationsUtilities, labour roles, and depreciation register
- Funding & liquidityDebt facilities, CAPEX, and working-capital schedules
- Risk & evidenceMonte Carlo, bankability, downside cases, and evidence register
- Advanced controlsAnnual drivers, tax, scenarios, simulation, viability, goal seek, and AI
- AI & RAG evidenceProject document upload, retrieval, cited AI review, and human approval
Review the result
Outputs and analysis
- NPVUSD m
- IRRAnnual
- PaybackYears
- Profitability indexx
- Average DSCRx
- Investor viability/ 100
- Minimum ending cashUSD m
- Probability NPV < 0Monte Carlo
- Financial statementsDetailed schedules
- Production & operating schedulesDetailed schedules
- Investment, bankability & scenariosDetailed schedules
- Risk & predictiveDetailed schedules
- Production report chart packDetailed schedules
Designed for review
Who this model is for
- Life-sciences founders and sponsors
- Production and commercial teams
- Financial advisers
- Investors and lenders
Governed evidence
The review trail stays with the result.
Each completed calculation preserves the model version, saved inputs, reporting-currency snapshot, immutable run, and result fingerprint used for its reports.
- Version-controlled calculation logic
- Saved assumptions and scenarios
- Immutable calculation runs
- Reporting context preserved in exports
Ready to explore the case?